ARCHIVES

ACS Challenged To Clarify Position On FDA Reform

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

DO RFAs cut Into R01 Grant Pool? Board Asks

July 2, 1999

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991

PhRMA Tightens DTC Restrictions, But Dingell Says It’s Not Enough.

December 12, 2008